Was Jeffrey Yu’s ONMD share transaction an open-market purchase?

Yes. The Form 4 classifies the 158,730-share transaction as a non-derivative open-market or private purchase, coded “P.” A footnote explains this came through a $100,000 subscription agreement with the issuer on June 23, 2026, for common stock.

OneMedNet (ONMD) CMO invests $100,000 to acquire additional shares

Filing Impact

(Neutral)

Filing Sentiment

(Positive)

Form Type

Rhea-AI Filing Summary

OneMedNet Corp Chief Medical Officer Jeffrey Yu reported a direct open-market purchase of 158,730 shares of Common Stock at $0.63 per share. This reflects a $100,000 investment under a subscription agreement dated June 23, 2026. After this transaction, he directly holds 8,780,410 shares. An additional 1,311,970 shares are held in a trust for his children with an independent trustee, where he has no investment control and disclaims beneficial ownership.

Insights

Yu’s filing shows a six-figure share purchase, with most holdings retained.

Chief Medical Officer Jeffrey Yu entered a subscription agreement for a $100,000 investment, acquiring 158,730 OneMedNet common shares at $0.63 each. Following this, his directly held position increased to 8,780,410 shares, with no derivative positions reported.

A separate 1,311,970-share block is held by a trust for his children under an independent trustee; Yu expressly disclaims beneficial ownership of those shares. The filing indicates a net-buy pattern of 158,730 shares, which appears as a routine increase in exposure based on the information provided.

Insider Trade Summary

Net Buyer: 158,730 shares ($100,000)

Net Buy 2 txns

Insider Yu Jeffrey

Role Chief Medical Officer

Bought 158,730 shs ($100K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	158,730	$0.63	$100K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 8,780,410 shares (Direct, null); Common Stock — 1,311,970 shares (Indirect, By trust for children)

Footnotes (1)

On June 23, 2026, the issuer entered into a subscription agreement with the reporting person for a $100,000 investment in the issuer. The shares are held by trust with an independent trustee, in which the reporting person has no investment control. The reporting person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the shares for purposes of Section 16 or for any other purpose.

Key Figures

Shares purchased: 158,730 shares Purchase price: $0.63 per share Investment amount: $100,000 +3 more

6 metrics

Shares purchased 158,730 shares Common Stock acquired at $0.63 on June 23, 2026

Purchase price $0.63 per share Price for non-derivative open-market purchase

Investment amount $100,000 Subscription agreement investment by reporting person

Direct holdings after 8,780,410 shares Total directly owned common shares after transaction

Trust-held shares 1,311,970 shares Held by trust for children; reporting person disclaims ownership

Net buy shares 158,730 shares Net-buy direction from transaction summary

Key Terms

subscription agreement, beneficial ownership, independent trustee, Section 16, +1 more

5 terms

subscription agreement financial

"the issuer entered into a subscription agreement with the reporting person for a $100,000 investment"

A subscription agreement is a legal contract in which an investor agrees to buy a specific number of a company’s shares or other securities under set terms, including price, payment method and conditions for closing the sale. It matters to investors because it legally locks in their purchase and the company’s obligations, determines ownership percentage and any investor rights, and can include conditions or promises that affect future control or returns—like signing a detailed purchase order for equity.

beneficial ownership regulatory

"The reporting person disclaims beneficial ownership of these shares"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

independent trustee financial

"The shares are held by trust with an independent trustee, in which the reporting person has no investment control"

Section 16 regulatory

"shall not be deemed an admission that the reporting person is the beneficial owner of the shares for purposes of Section 16"

Section 16 is a U.S. securities law rule that governs the trading and disclosure obligations of company insiders — typically officers, directors and large shareholders — to promote transparency and deter unfair profit-taking. It requires insiders to publicly report their stock trades and allows companies or the issuer to reclaim quick, short-term profits from certain insider trades, like a scoreboard and a refund policy that help investors see and limit possible insider advantage.

open-market purchase financial

"transaction_action": "open-market purchase""

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/24/2026 - 09:00 AM Accepted by SEC EDGAR 06/24/2026 - 09:00 AM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Yu Jeffrey

(Last)

(First)

(Middle)

6385 OLD SHADY OAK ROAD,

SUITE 250

(Street)

EDEN PRAIRIE

MINNESOTA

55344

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
OneMedNet Corp [ ONMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Medical Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/23/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	06/23/2026		P⁽¹⁾		158,730	A	$0.63	8,780,410	D
Common Stock								1,311,970	I	By trust for children⁽²⁾

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. On June 23, 2026, the issuer entered into a subscription agreement with the reporting person for a $100,000 investment in the issuer.

2. The shares are held by trust with an independent trustee, in which the reporting person has no investment control. The reporting person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the shares for purposes of Section 16 or for any other purpose.

	/s/ Robert Golden, Attorney-in-Fact	06/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did OneMedNet (ONMD) Chief Medical Officer Jeffrey Yu report in this Form 4?

Jeffrey Yu reported buying 158,730 shares of OneMedNet common stock at $0.63 per share, reflecting a $100,000 investment. After the purchase, his directly owned holdings increased to 8,780,410 shares, according to the Form 4 data.

At what price did Jeffrey Yu acquire additional ONMD shares?

Jeffrey Yu acquired 158,730 OneMedNet (ONMD) common shares at $0.63 per share. The transaction corresponds to a $100,000 investment through a subscription agreement dated June 23, 2026, as disclosed in the Form 4 filing footnote.

How many OneMedNet (ONMD) shares does Jeffrey Yu hold after this transaction?

After the reported transaction, Jeffrey Yu directly holds 8,780,410 shares of OneMedNet common stock. The Form 4 also shows 1,311,970 additional shares held in a trust for his children, where he has no investment control and disclaims beneficial ownership.

What is the role of the trust mentioned in Jeffrey Yu’s ONMD Form 4?

The trust holds 1,311,970 OneMedNet shares for Jeffrey Yu’s children under an independent trustee. Yu has no investment control over these shares and disclaims beneficial ownership, meaning they are legally separated from his direct economic interest under Section 16 rules.

Does Jeffrey Yu have any reported ONMD derivative securities in this filing?

No derivative securities are listed for Jeffrey Yu in this Form 4. The derivative section is empty, and the transaction summary shows zero derivative exercises or derivative transactions, focusing solely on common stock holdings and purchases.